The insurer’s alternative-credit arm is aiming to raise its fourth fund under its CQS regulatory capital strategy. It comes less than a year after raising US$1.1 billion for its third fund. (Bloomberg, The Logic)

Talking point: The new fund targets an internal return rate of about 13 per cent, Bloomberg reported, compared with more than 11 per cent for its previous vintage at the end of March. The fund is expected to invest mainly in significant risk transfers (SRTs) tied to corporate loans across Europe, North America and Asia. SRTs let banks transfer some of the credit risk in their loan portfolios to investors, freeing up regulatory capital for new lending or shareholder payouts. Manulife Investment Management acquired the London-based alternative-credit manager in 2024, gaining a platform that has invested in SRTs since 2014. Global SRT sales topped US$18 billion in the first half of 2026, up from about US$15 billion a year earlier, according to Crescent Capital.

Sponsored Content

The real-world economic offshoots of sovereign AI

By Deborah Aarts

Increasing healthcare access across Canada

By Deborah Aarts

What it takes to lead a frontier firm

By Deborah Aarts

Paid promotional content